Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;54(1):8-13.
doi: 10.1007/s00795-020-00255-5. Epub 2020 May 15.

Differences in autoimmune hepatitis based on inflammation localization

Affiliations

Differences in autoimmune hepatitis based on inflammation localization

Atsushi Takahashi et al. Med Mol Morphol. 2021 Mar.

Abstract

Histopathology is essential for the diagnosis and evaluation of disease activity of autoimmune hepatitis (AIH). We aimed to elucidate the characteristics of AIH from the localization of inflammation. We re-evaluated a nationwide survey that was performed in Japan in 2018 of AIH patients diagnosed between 2014 and 2017. A total of 303 patients were enrolled, and the clinical and treatment characteristics were compared between the patients with predominantly portal inflammation (230 patients) or lobular inflammation (73 patients). AIH patients with lobular inflammation had a higher probability of being diagnosed with acute hepatitis than those with portal inflammation. Liver enzyme levels were higher in patients with lobular inflammation, whereas immunoglobulin G levels were higher in patients with portal inflammation. The prevalence of an alanine aminotransferase level < 30 U/L after 6 months of treatment was significantly higher in patients with lobular inflammation than in those with portal inflammation (81.7% vs. 67.3%, P = 0.046). The localization of inflammation may be useful for evaluating the onset of AIH.

Keywords: Acute hepatitis; Autoimmune hepatitis; Lobular inflammation; Portal inflammation; Treatment.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Harada K, Hiep NC, Ohira H (2017) Challenges and difficulties in pathological diagnosis of autoimmune hepatitis. Hepatol Res 47:963–971 - DOI
    1. Tiniakos DG, Brain JG, Bury YA (2015) Role of histopathology in autoimmune hepatitis. Dig Dis 33:53–64 - DOI
    1. Onji M, Zeniya M, Yamamoto K, Tsubouchi H (2013) Autoimmune hepatitis: Diagnosis and treatment guide in Japan. Hepatol Res 44:368–370 - DOI
    1. Abe M, Onji M (2014) Acute presentation of autoimmune hepatitis. In: Ohira H (ed) Autoimmune liver diseases. Springer, Berlin, pp 83–94
    1. Takahashi A, Arinaga-Hino T, Ohira H, Torimura T, Zeniya M, Abe M, Yoshizawa K, Takaki A, Suzuki Y, Kang JH, Nakamoto N, Fujisawa T, Yonemoto K, Tanaka A, Takikawa H, Autoimmune Hepatitis Study Group-Subgroup of the Intractable Hepato-Biliary Disease Study Group in Japan (2017) Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol 52:631–640 - DOI

MeSH terms

LinkOut - more resources